Therefore, AS-IV may improve cognitive impairment by binding to AD-related gene, such as caspase-1, TRPV1, PSEN1, and GSK3Β, reduce cell death, and ultimately inhibit AD-phenotypes. This evidence concerns the gene TRPV1 and Cognitive impairment.